Chargement en cours...
Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients
BACKGROUND: This study investigated the pharmacokinetics, pharmacodynamics, and safety of multiple doses of evocalcet in Japanese secondary hyperparathyroidism (SHPT) patients receiving hemodialysis. METHODS: In this multicenter, open-label study, conducted between August 2013 and March 2014, 27 pat...
Enregistré dans:
| Publié dans: | Clin Exp Nephrol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Singapore
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6510802/ https://ncbi.nlm.nih.gov/pubmed/30159688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-018-1635-6 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|